InvestorsHub Logo
icon url

ranchhand71

01/26/23 11:04 AM

#27282 RE: biotech48 #27281

FULLY AGREE but it does not seem as high a priority for current management.
Excellent that they got several government funding grants and support.
Their long term belief in sepsis market has been narrowed to several smaller markets.
NAE has the cash, existing distribution in plasma, hospitals and blood banks already. In an acquisition HAE would not need any of CTSO executives. I hope it leads to a stock acquisition in the $10-15 value range.